Sudipta Mukherjee,
Mrinmoy Ghosh,
Rituparna Chatterjee,
- Assistant Professor, Department of Medical Laboratory Technology, Global College of Science and Technology, Bhatjangla, Krishnanagar, West Bengal, India
- Student, Department of Medical Laboratory Technology, Global College of Science and Technology, Bhatjangla, Krishnanagar, West Bengal, India
- Assistant Professor, Department of Medical Laboratory Technology, Global College of Science and Technology, Bhatjangla, Krishnanagar, West Bengal, India
Abstract
Human Immunodeficiency Virus (HIV) remains a critical global health concern, infecting millions of individuals each year. The introduction of antiretroviral therapy (ART) has markedly improved disease outcomes by suppressing viral replication, restoring immune function, and extending patient longevity. Despite these advances, the complete eradication of HIV is hindered by the persistence of viral reservoirs, the emergence of drug-resistant strains, and disparities in healthcare accessibility. This review summarizes key developments in HIV epidemiology, virology, and pathogenesis, emphasizing recent innovations in ART, gene-editing technologies such as CRISPR, and ongoing vaccine research. Additionally, it explores the socioeconomic implications of the disease and highlights integrated strategies for prevention and control. Achieving long-term containment and eventual eradication of HIV will require a coordinated effort combining scientific breakthroughs with equitable public health policies
Keywords: HIV, antiretroviral therapy, CRISPR, viral pathogenesis, epidemiology, vaccine development
[This article belongs to International Journal of Pathogens ]
Sudipta Mukherjee, Mrinmoy Ghosh, Rituparna Chatterjee. Advances In HIV Research: Epidemiology, Pathogenesis, And Emerging Therapeutic Strategies. International Journal of Pathogens. 2026; 03(01):1-5.
Sudipta Mukherjee, Mrinmoy Ghosh, Rituparna Chatterjee. Advances In HIV Research: Epidemiology, Pathogenesis, And Emerging Therapeutic Strategies. International Journal of Pathogens. 2026; 03(01):1-5. Available from: https://journals.stmjournals.com/ijpg/article=2026/view=237788
References
1. World Health Organization. HIV/AIDS: key facts. Geneva: World Health Organization; 2024. Available from: https://www.who.int. 2. Sharp PM, Hahn BH. Origins of HIV and the AIDS pandemic. Cold Spring Harb Perspect Med. 2011;1(1):a006841. 3. World Health Organization. Global HIV and AIDS statistics: fact sheet 2024. Geneva: WHO; 2024. Available from: https://www.who.int. 4. Barre-Sinoussi F, Chermann JC, Rey F, Nugeyre MT, Chamaret S, Gruest J, et al. Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immunodeficiency syndrome (AIDS). Science. 1983;220(4599):868–871. 5. National AIDS Control Organization. India HIV estimations 2023. New Delhi: Ministry of Health and Family Welfare, Government of India; 2023. Available from: http://naco.gov.in. 6. Joint United Nations Programme on HIV/AIDS (UNAIDS). UNAIDS data 2024. Geneva: UNAIDS; 2024. Available from: https://www.unaids.org. 7. Freed EO. HIV-1 assembly, release, and maturation. Nat Rev Microbiol. 2015;13(8):484–496. 8. Sloan RD, Wainberg MA. The role of unintegrated DNA in HIV infection. Retrovirology. 2011;8:52. 9. Centers for Disease Control and Prevention. HIV transmission overview. Atlanta: CDC; 2023. Available from: https://www.cdc.gov. 10. Panel on Treatment of HIV During Pregnancy and Prevention of Perinatal Transmission. Perinatal HIV treatment guidelines. Washington, DC: U.S. Department of Health and Human Services; 2023. Available from: https://clinicalinfo.hiv.gov. 11. Douek DC, Roederer M, Koup RA. HIV disease progression: immune activation, microbes, and inflammation. Nat Immunol. 2009;10(11):1159–1167. 12. Fauci AS, Lane HC. HIV disease: AIDS and related disorders. In: Jameson JL, Fauci AS, Kasper DL, et al., editors. Harrison’s principles of internal medicine. 21st ed. New York: McGraw-Hill Education; 2022. 13. Centers for Disease Control and Prevention. HIV testing technologies and guidelines. Atlanta: CDC; 2024. Available from: https://www.cdc.gov. 14. Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in adults and adolescents with HIV. Washington, DC: U.S. Department of Health and Human Services; 2023. Available from: https://clinicalinfo.hiv.gov. 15. Orkin C, Arasteh K, Górgolas Hernández-Mora M, Pokrovsky V, Overton ET, Girard PM, et al. Long-acting cabotegravir and rilpivirine for HIV-1 treatment. N Engl J Med. 2020;382:1124–1135. 16. Corey L, Gilbert PB, Juraska M, Montefiori DC, Morris L, Karuna ST, et al. HIV vaccines: current status and future directions. N Engl J Med. 2021;384(10):918–932. 17. Dash PK, Kaminski R, Bella R, Su H, Mathews S, Ahooyi TM, et al. Long-term CRISPR-based editing of latent HIV provirus in vivo. Nat Commun. 2019;10:2753. 18. Grant RM, Lama JR, Anderson PL, McMahan V, Liu AY, Vargas L, et al. Pre-exposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med. 2010;363:2587–2599. 19. Joint United Nations Programme on HIV/AIDS (UNAIDS). 95–95–95: an ambitious treatment target to help end the AIDS epidemic. Geneva: UNAIDS; 2024. Available from: https://www.unaids.org. 20. Gupta RK, Gregson J, Parkin N, Haile-Selassie H, Tanuri A, Andrade Forero L, et al. HIV co-infections and comorbidities: clinical implications for treatment. Lancet HIV. 2022;9(3):e182–e195. 21. Logie CH, Gadalla TM. Meta-analysis of stigma and mental health among people living with HIV. Soc Sci Med. 2009;68(9):1551–1557. 22. Xu L, Wang J, Liu Y, Xie L, Su B, Mou D, et al. CRISPR-edited stem cells for HIV therapy. Nat Biotechnol. 2022;40(2):259–268.
International Journal of Pathogens
| Volume | 03 |
| Issue | 01 |
| Received | 08/12/2025 |
| Accepted | 17/12/2025 |
| Published | 25/01/2026 |
| Publication Time | 48 Days |
Login
PlumX Metrics